Winship Logo

Emory Glenn Family Breast Center Publications

December 202410 publications

AuthorsDate PublishedJournalTitle
Baek Kim
12/29/2024Nature communicationsNOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression.
Ritu Aneja
12/20/2024International journal of molecular sciencesDysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer.
Manali Bhave
12/09/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyImlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study.
Kevin C Ward
12/05/2024JCO oncology practiceOncology and Primary Care Involvement in Breast Cancer Survivorship Care More Than 5 Years After Initial Treatment.
Kevin Kalinsky
12/04/2024Journal of the National Cancer InstituteRace and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial.
Manali Bhave
12/01/2024Clinical cancer research : an official journal of the American Association for Cancer ResearchA Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study.
Ilana Graetz
11/30/2024JCO clinical cancer informaticsSymptom Monitoring App Use Associated With Medication Adherence Among Woman Survivors of Breast Cancer on Adjuvant Endocrine Therapy.
Curtis J Henry
11/30/2024LeukemiaMERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity.
Jane L Meisel
Kevin M Kalinsky
11/30/2024Nature medicineDatopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Kevin Kalinsky
11/30/2024Nature medicineDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.

November 20244 publications

AuthorsDate PublishedJournalTitle
Kevin Kalinsky
11/19/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for <i>PIK3CA</i>-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer.
Gulisa Turashvili
Xiaoxian Li
11/18/2024Journal of clinical pathologyLow interobserver agreement among subspecialised breast pathologists in evaluating HER2-low breast cancer.
Kevin Kalinsky
Manali Ajay Bhave
10/31/2024Breast cancer research and treatmentReal-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States.
Manali Bhave
Jane L Meisel
Mylin A Torres
Toncred M Styblo
Cathy L Graham
Kevin Kalinsky
Jeffrey Switchenko
David M Schuster
10/31/2024European journal of nuclear medicine and molecular imagingProspective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma.

October 202410 publications

AuthorsDate PublishedJournalTitle
Kevin Kalinsky
10/30/2024The New England journal of medicineInavolisib-Based Therapy in <i>PIK3CA</i>-Mutated Advanced Breast Cancer.
Anant Madabhushi
09/30/2024Advances in radiation oncologyLaterality of Radiation Therapy in Breast Cancer is Not Associated With Increased Risk of Coronary Artery Disease in the Contemporary Era.
Lauren M Postlewait
Cletus A Arciero
09/30/2024Annals of surgical oncologyClipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
Cletus Arciero
Jade Jones
Lauren M Postlewait
09/30/2024Annals of surgical oncologyDefining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
Lauren Postlewait
09/30/2024Annals of surgical oncologyInternal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.
Gulisa Turashvili
Sunil Shankar Badve
09/30/2024Archives of pathology & laboratory medicineIdentification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition.
Manali A Bhave
Kevin Kalinsky
09/30/2024Breast cancer research and treatmentComprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice.
Xiaoxian Li
09/30/2024Cancer research communicationsTumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast Cancer.
Ilana Graetz
Jane Meisel
Keerthi Gogineni
Mylin A Torres
09/30/2024JCO oncology practiceLeveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial.
Jeffrey M Switchenko
Karen Godette
Monica Rizzo
09/30/2024Journal of surgical oncologyIntraoperative radiation therapy for early-stage breast cancer.

September 20246 publications

AuthorsDate PublishedJournalTitle
Cathy Graham
09/26/2024BMC medical informatics and decision makingUse of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904).
Lauren E McCullough
09/14/2024International journal of cancerSecond primary cancer risks according to race and ethnicity among U.S. breast cancer survivors.
Mylin A Torres
09/10/2024BMJ (Clinical research ed.)Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis.
Kevin C Ward
09/09/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyGenetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer.
Lauren M Postlewait
Xiaoxian Li
08/31/2024Breast cancer research and treatmentChanges in expression of breast cancer tumor biomarkers between primary tumors and corresponding metastatic sites: common patterns and relationships with survival.
Michael Goodman
Lauren E McCullough
Timothy L Lash
08/31/2024Epidemiology (Cambridge, Mass.)The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend Design.

August 20245 publications

AuthorsDate PublishedJournalTitle
Kevin Kalinsky
07/31/2024EMBO molecular medicineFLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer.
Demetria J Smith-Graziani
Reshma Jagsi
07/31/2024International journal of radiation oncology, biology, physicsOut-of-Pocket Cost Modeling of Adjuvant Antiestrogen and Radiation Therapy After Lumpectomy for Early-Stage Breast Cancer Across Medicaid and Medicare Plans.
Sunil S Badve
07/31/2024JAMA oncologyTumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy.
Xiaoxian Li
07/31/2024Modern pathology : an official journal of the United States and Canadian Academy of Pathology, IncBreast Cancer With HER2 Immunohistochemical Score 2 and Average HER2 Signals/Cell 6 or More and HER2/CEP17 Ratio Less Than 2 ('ISH Group 3'): A Multi-Institutional Cohort Analysis Emphasizing Outcome and Molecular Subtype.
Sunil S Badve
07/31/2024NEJM evidenceClinical and Genomic Risk for Late Breast Cancer Recurrence and Survival.

July 20244 publications

AuthorsDate PublishedJournalTitle
Ritu Aneja
07/28/2024Clinical proteomicsQuantitative proteomics reveals serum proteome alterations during metastatic disease progression in breast cancer patients.
Reshma Jagsi
07/14/2024International journal of radiation oncology, biology, physicsAre We Missing Acute Toxicities Associated With Hypofractionated Breast Irradiation? A Report From a Large Multicenter Cohort Study.
C Graham
06/30/2024Contemporary clinical trialsMaking Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial.
Kevin Kalinsky
06/30/2024JCO oncology practiceThe Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of Life.

June 20246 publications

AuthorsDate PublishedJournalTitle
Jane Meisel
06/09/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyPACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer.
Joellen Schildkraut
06/05/2024American journal of human geneticsCis- and trans-eQTL TWASs of breast and ovarian cancer identify more than 100 susceptibility genes in the BCAC and OCAC consortia.
Jeffrey M Switchenko
Kevin C Ward
Lauren E McCullough
06/02/2024JAMA network openNeighborhood Deprivation and Breast Cancer Mortality Among Black and White Women.
Ilana Graetz
06/02/2024JAMA network openRemote Monitoring App for Endocrine Therapy Adherence Among Patients With Early-Stage Breast Cancer: A Randomized Clinical Trial.
Jade Jones
Jeffrey M Switchenko
Kevin C Ward
Lauren E McCullough
05/31/2024Breast cancer research and treatmentRacial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia.
Jinbing Bai
05/31/2024European journal of oncology nursing : the official journal of European Oncology Nursing SocietyThe impact of fear of cancer recurrence on the quality of life of breast cancer patients: A longitudinal study of the mediation effect of cortisol and hope.

May 20243 publications

AuthorsDate PublishedJournalTitle
Kevin Kalinsky
05/19/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyFinal Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression.
Ramireddy Bommireddy
Adam Marcus
Periasamy Selvaraj
05/14/2024International journal of molecular sciencesTumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model.
Jane L Meisel
Xiaoxian Li
04/30/2024Breast cancer research and treatmentHigh tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy.

April 20243 publications

AuthorsDate PublishedJournalTitle
Kevin Kalinsky
04/24/2024NPJ breast cancerSubgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
Timothy L Lash
04/07/2024Breast cancer research : BCRClinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients.
Gulisa Turashvili
Xiaoxian Li
03/31/2024Breast cancer research and treatmentSubspecialized breast pathologists have suboptimal interobserver agreement in Ki-67 evaluation using 20% as the cutoff.

March 20246 publications

AuthorsDate PublishedJournalTitle
Yueming Zhu
Andrey A Ivanov
Curtis J Henry
Theresa W Gillespie
Manali Ajay Bhave
Kevin Kalinsky
Haian Fu
Yong Wan
03/25/2024The Journal of clinical investigationPharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers.
Yong Wan
03/04/2024The Journal of clinical investigationCD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione/GPX4.
Kevin Kalinsky
02/29/2024Future oncology (London, England)TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer.
Reshma Jagsi
02/29/2024International journal of radiation oncology, biology, physicsRacial and Ethnic Differences in Long-Term Adverse Radiation Therapy Effects Among Breast Cancer Survivors.
Lauren M Postlewait
Theresa Gillespie
Cletus A Arciero
02/29/2024Journal of surgical oncologyPatterns of completion axillary dissection for patients with cT1-2N0 breast cancer undergoing total mastectomy with positive sentinel lymph nodes.
Sunil Badve
Xiaoxian Li
Anant Madabhushi
02/29/2024The Journal of pathologyImage-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.

February 20248 publications

AuthorsDate PublishedJournalTitle
Sunil Badve
02/23/2024NPJ breast cancerLumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 study.
Jeffrey M Switchenko
Kevin C Ward
Lauren E McCullough
02/04/2024JAMA network openHistorical Redlining, Persistent Mortgage Discrimination, and Race in Breast Cancer Outcomes.
Kevin Kalinsky
01/31/2024Breast cancer research and treatmentRandomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer.
Keerthi Gogineni
01/31/2024JCO precision oncologySunitinib in Patients With Breast Cancer With <i>FGFR1</i> or <i>FGFR2</i> Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Reshma Jagsi
01/31/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyOmission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
Kevin C Ward
Lauren E McCullough
01/31/2024Journal of urban health : bulletin of the New York Academy of MedicineA Comparison of Three Area-Level Indices of Neighborhood Deprivation and Socioeconomic Status and their Applicability to Breast Cancer Mortality.
Jane Meisel
01/31/2024Modern pathology : an official journal of the United States and Canadian Academy of Pathology, IncCorrelation of HER2 Protein Level With mRNA Level Quantified by RNAscope in Breast Cancer.
Reshma Jagsi
01/31/2024Seminars in plastic surgeryFinancial Toxicity in Breast Reconstruction: The Role of the Surgeon-Patient Cost-of-Care Discussion.

January 202411 publications

AuthorsDate PublishedJournalTitle
Ritu Aneja
01/17/2024Breast cancer research : BCRDigital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer.
Kevin Kalinsky
01/10/2024Nature communicationsThe HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results.
Susan Modesitt
Anant Madabhushi
01/02/2024Communications medicineComputational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignancies.
Sheryl Gordon Ann Gabram-Mendola
12/31/2023Frontiers in health servicesAddressing disparities in cancer clinical trials: a roadmap to more equitable accrual.
Mia M Gaudet
12/31/2023Nature medicineA population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer.
Jinbing Bai
12/31/2023Nursing openPsychological experiences of family caregivers of patients with breast cancer: Protocol for a meta-synthesis.
Reshma Jagsi
12/31/2023Practical radiation oncologyOut-of-Pocket Cost Modeling of Adjuvant Radiation Therapy Duration in Standard-of-Care Early Stage Breast Cancer Treatment Across Medicaid and Medicare Plans.
Reshma Jagsi
12/31/2023Practical radiation oncologyPectoralis Muscle Dosimetry and Posttreatment Rehabilitation Utilization for Patients With Early-Stage Breast Cancer.
Reshma Jagsi
12/31/2023Practical radiation oncologyThe Effect of Wire Versus Magnetic Seed Localization on Lumpectomy Cavity Size.
David H Howard
12/31/2023Public health reports (Washington, D.C. : 1974)Variation in State-Level Mammography Use, 2012 and 2020.
Kevin Kalinsky
12/31/2023Therapeutic advances in medical oncologyTROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy.